Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials.
Lewiecki
E M
EM
New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM 87106, USA. lewiecki@aol.com
Cooper
C
C
Thompson
E
E
Hartl
F
F
Mehta
D
D
Papapoulos
S E
SE